Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel H Greig

Showing results (81-90 of 332) with videos related to

Pageof 34
Sort By:
AAPS Pharmscitech|August 27, 2024
Gastroretentive Delivery Approach to Address pH-Dependent Degradation of (+)- and (-)-PhenserinePratishtha Verma, Leyla Rezaei, Ramprakash Govindarajan, et al.
Clinical Neuropharmacology|December 7, 2002
Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmineIrene Hegeman Richard, Anne Wallace Justus, Nigel H Greig, et al.
Current Pharmaceutical Design|February 11, 2017
Adiponectin as a Potential Therapeutic Target for Prostate CancerHanuma Kumar Karnati, Manas Kumar Panigrahi, Yazhou Li, et al.
Biomolecules|July 27, 2024
Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of NeurodegenerationKatherine O Kopp, Yazhou Li, Elliot J Glotfelty, et al.
CNS & Neurological Disorders Drug Targets|May 16, 2012
Molecular docking study of catecholamines and [4-(propan-2-yl) phenyl]carbamic acid with tyrosine hydroxylaseZahida Parveen, Muhammad Sulaman Nawaz, Shazi Shakil, et al.
Biogerontology|August 1, 2008
Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" modelDebomoy K Lahiri, Nasser H Zawia, Nigel H Greig, et al.
Expert Opinion on Investigational Drugs|May 16, 2020
Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's diseaseElliot J Glotfelty, Lars Olson, Tobias E Karlsson, et al.
Plos One|August 15, 2018
Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse modelEmanuele Schiavon, Joshua L Smalley, Sherylanne Newton, et al.
Annals of the New York Academy of Sciences|January 3, 2006
Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseasesDebomoy K Lahiri, De-Mao Chen, Preeti Lahiri, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2007
Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserineAmelia Marutle, Masao Ohmitsu, Mats Nilbratt, et al.
Pageof 34

Showing results (81-90 of 332) with videos related to

Sort By:
Pageof 34
AAPS Pharmscitech|August 27, 2024
Gastroretentive Delivery Approach to Address pH-Dependent Degradation of (+)- and (-)-PhenserinePratishtha Verma, Leyla Rezaei, Ramprakash Govindarajan, et al.
Clinical Neuropharmacology|December 7, 2002
Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmineIrene Hegeman Richard, Anne Wallace Justus, Nigel H Greig, et al.
Current Pharmaceutical Design|February 11, 2017
Adiponectin as a Potential Therapeutic Target for Prostate CancerHanuma Kumar Karnati, Manas Kumar Panigrahi, Yazhou Li, et al.
Biomolecules|July 27, 2024
Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of NeurodegenerationKatherine O Kopp, Yazhou Li, Elliot J Glotfelty, et al.
CNS & Neurological Disorders Drug Targets|May 16, 2012
Molecular docking study of catecholamines and [4-(propan-2-yl) phenyl]carbamic acid with tyrosine hydroxylaseZahida Parveen, Muhammad Sulaman Nawaz, Shazi Shakil, et al.
Biogerontology|August 1, 2008
Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" modelDebomoy K Lahiri, Nasser H Zawia, Nigel H Greig, et al.
Expert Opinion on Investigational Drugs|May 16, 2020
Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's diseaseElliot J Glotfelty, Lars Olson, Tobias E Karlsson, et al.
Plos One|August 15, 2018
Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse modelEmanuele Schiavon, Joshua L Smalley, Sherylanne Newton, et al.
Annals of the New York Academy of Sciences|January 3, 2006
Amyloid, cholinesterase, melatonin, and metals and their roles in aging and neurodegenerative diseasesDebomoy K Lahiri, De-Mao Chen, Preeti Lahiri, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2007
Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserineAmelia Marutle, Masao Ohmitsu, Mats Nilbratt, et al.
Pageof 34